Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can virtual reality spark emotion in dementia patients?

NCT ID NCT07468305

Symptom relief Sponsor: Centre Hospitalier Universitaire de Nice Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a personalized virtual reality program that uses sights, sounds, smells, and tastes can reduce apathy in older adults with cognitive impairment living in nursing homes. Ten participants will attend weekly sessions for six weeks, reliving meaningful memories in an immersive environment. The main goal is to see if this approach is feasible and well-tolerated, with early signs of improved motivation and engagement.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
multisensory virtual reality reminiscence therapy
What this could lead to
If it works, this could offer a drug-free way to reduce apathy and improve engagement in older adults with dementia living in care homes.
What could go wrong
This is a very small pilot study with only 10 participants, so results may not apply broadly. It is also early-stage and focuses on feasibility, not proven effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 10 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Men or women aged 70 years or older * Living in a nursing home (EHPAD) or long-term care unit (USLD) for at least 3 months * Sufficient French language ability to understand the study procedures * Presence of apathy confirmed by a positive score on the Apathy Inventory * Moderate cognitive impairment documented by a Montreal Cognitive Assessment (MoCA) score between 10 and 17 * Affiliated with a social security or health insurance system * Medical approval for virtual reality exposure (no contraindication) * Ability to provide informed consent, or consent provided by a legal representative or trusted person when applicable Exclusion Criteria: * "Diagnosed psychiatric disorder according to DSM-5 criteria (e.g., schizophrenia, bipolar disorder) * Severe or acute behavioral disturbances incompatible with study participation * Neurological comorbidities incompatible with virtual reality use (e.g., Lewy body disease, history of epilepsy) * Severe sensory impairment (vision, hearing, or olfaction) preventing participation * Known susceptibility to cybersickness based on the CyberSickness in Virtual Reality Questionnaire (CSQ-VR) * Presence of a cardiac pacemaker incompatible with virtual reality headset use * Withdrawal of informed consent at any time during the study"

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APATHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cognitive disorder dementia Lethargy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

APATHY Apathy in dementia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU de Nice - Hôpital de Cimiez

    Nice, 06000, France

  • EPHAD Villa de Rimiez

    Nice, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.